Geron carried out a Phase 1 clinical trial to assess the safety and preliminary activity of escalating doses of human embryonic stem cell (hESC) derived oligodendrocyte progenitor cells for treatment… ...

Research Objective We will identify SAR-CoV-2 T cell epitopes for vaccine development and specific TCRs for adoptive T cell therapy using a stem cell-based platform to generate specialized dendritic ...

SAN FRANCISCO, September 5, 2006 – The California Institute for Regenerative Medicine (CIRM) announced today that it has named Marcia Davey as Interim Financial Officer. The one-year appointment is ...

Late Stage Preclinical Projects Aaron Nagiel Development of a novel intravitreal AAV gene therapy for the rare disease blue cone monochromacy. $4,691,936 Get the latest CIRM news, information on ...

The Strategic Allocation Framework (SAF) reflects a refined vision to ensure that CIRM’s investments are aligned with its mission.

We are deeply saddened to learn of the passing of a subject enrolled in Rocket Pharmaceuticals’ Phase 2 clinical trial of RP-A501 to treat Danon disease. On behalf of the California Institute for ...

SAN DIEGO, Calif., September 25, 2008 – Governor Arnold Schwarzenegger has declared Sept. 25 to be Stem Cell Awareness Day. In the proclamation he said, “The discoveries being made today in our Golden ...

癌症的靶向治疗通常集中于抑制剂（例如酪氨酸激酶抑制剂），其将致癌信号传导抑制到癌细胞生存和增殖所需的最低阈值以下。 B细胞急性淋巴细胞白血病和B细胞淋巴瘤起源于B细胞的各个发育 ...

不同细胞类型的定向迁移在从发育和形态发生到免疫反应、伤口愈合和再生的生物过程中发挥着关键作用。然而，以特定且简便的方式指导、操纵和研究体外和体内细胞迁移的技术目前还很有限。

South San Francisco, CA, May 29, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, awarded $4.7 million to ...

This meeting of the Application Review Subcommittee will be conducted in person and via noticed teleconference locations, which will be made accessible to the public. Members of the public may attend ...